<DOC>
	<DOCNO>NCT03043196</DOCNO>
	<brief_summary>The purpose present study evaluate effect subgingival delivery Rosuvastatin gel adjunct scale root plan Smokers With Chronic Periodontitis ( CP ) patient .</brief_summary>
	<brief_title>1.2 % Rosuvastatin Gel As A Local Agent In Smokers With Chronic Periodontitis</brief_title>
	<detailed_description>Background : Periodontal disease multi-factorial etiology , bacteria one among etiologic agent . However , mechanical therapy may always reduce eliminate anaerobic infection base pocket , within gingival tissue . To overcome , various systemic local drug deliver antimicrobial use adjunct scale root planing ( SRP ) .The present study aim explore efficacy 1.2 % rosuvastatin ( RSV ) gel local drug delivery adjunct SRP smoker chronic periodontitis ( CP ) . Methods : Sixty subject randomly allocate two treatment group : SRP placebo gel ( group 1 ) , SRP 1.2 % RSV gel ( group 2 ) . Clinical parameter record baseline , 6 9 month . Radiographic assessment do use computer aid software baseline , 6 9 month .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Systemically healthy CP subject age 3050 year current smoker history periodontal therapy use antibiotic past 6 month , sit intrabony defect depth ( IBD ) ≥ 3mm ( distance alveolar crest base defect intraoral periapical radiograph ) along PPD ≥5 mm CAL ≥3 mm asymptomatic tooth include study . A subject consider current smoker regularly smoke 10 cigarettes/day minimum 5 year Former smoker , i.e . subject previously smoker stop habit , nonsmoker exclude . Subjects allergic statin , systemic statin therapy , know systemic disease systemic inflammation/ infection could alter course periodontal disease user tobacco form cigarette exclude study</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>